Detalhe da pesquisa
1.
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
J Med Genet
; 52(11): 770-8, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26318770
2.
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy.
Br J Cancer
; 100(8): 1330-5, 2009 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-19367287
3.
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
J Med Genet
; 45(8): 535-8, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18511570
4.
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.
J Med Genet
; 43(6): 531-3, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16258005
5.
A new genotoxicity assay based on p53 target gene induction.
Mutat Res Genet Toxicol Environ Mutagen
; 789-790: 28-35, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26232255
6.
TP63 gene mutation in ADULT syndrome.
Eur J Hum Genet
; 9(8): 642-5, 2001 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-11528512
7.
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
J Med Genet
; 38(4): 253-7, 2001 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-11370630